With CMC Navigator™, ProBioGen provides biopharma companies with four clearly defined CMC pathways – enabling aligned scope, timelines, and execution from first-in-human to scalable production.
Berlin, Germany – February 17, 2026
ProBioGen today introduces CMC Navigator™, a set of four clearly defined CMC service models designed to support biopharmaceutical companies across all key stages of protein Chemistry, Manufacturing and Controls (CMC) development. Each model addresses a distinct development or program need, helping teams navigate flexible CMC strategies and align scope, timelines, and execution with current priorities, ultimately adding value as programs move forward.
As biologics programs advance, CMC requirements evolve, biopharma teams need adaptable solutions that meet them wherever they are in their journey – whether the priority is accelerating first-in-human entry, preparing for seamless later-stage transfer, outsourcing specific CMC activities, or improving an underperforming cell line or manufacturing process. CMC Navigator addresses this variability by offering clear entry points, transparent scope, and a structured view of how ProBioGen supports different CMC needs across all development stages.
CMC Navigator translates ProBioGen’s expertise in protein CMC into a clear, structured, easy-to-navigate CMC collaboration framework. It enables teams to select the most appropriate CMC approach from the outset – without limiting scientific flexibility. At the heart of CMC Navigator are four defined CMC collaboration models, each aligned with a specific development need and set of priorities:
"CMC Navigator is a practical collaboration framework shaped by what we see across client programs," said Dr. Gabriele Schneider, Chief Business Officer at ProBioGen. "In protein CMC, success often depends on making the right calls early—on scope, timing, and how the work will be executed. CMC Navigator helps biopharma teams navigate those decisions by selecting one of the four paths, so they can choose the setup that fits their situation and move forward with aligned expectations and a clear plan from the start."
By moving beyond one-size-fits-all CMC approaches, CMC Navigator combines defined CMC service models with scientific adaptability – strengthening how ProBioGen supports its clients and providing even greater clarity as programs move from development decisions into clinical execution.
Learn more about ProBioGen’s CMC Navigator here.
About ProBioGen
ProBioGen is a Berlin-based expert in the development and manufacturingof biopharmaceuticals, viral vectors, and vaccines, powered by proprietarytechnologies that enhance product quality and features. Operating for over 30 years, ProBioGen runs three manufacturing lines in Berlin, where 300 employees contribute to advancing next-generation therapies and global biotech innovation. The company’s growth strategy focuses on expanding its servicevalue chain through organic growth and strategic opportunities, with a clearmission to enable tomorrow’s biopharmaceuticals.
For more information aboutProBioGen, follow us on LinkedIn.